MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jcv.2021.104907

Медицинская библиотека · Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2021

A second external quality assessment of isolation and identification of influenza viruses in cell culture in the Asia Pacific region highlights improved performance by participating laboratories.

Leung Vivian K Y, Deng Yi-Mo, Todd Angela, Peck Heidi, Buettner Iwona, Zakis Tasoula, Subbarao Kanta, Barr Ian G, Nahapetyan Karen, Inbanathan Francis Y, Samaan Magdi, Reading Patrick C

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Influenza viruses must be amplified in cell culture for detailed antigenic analysis and for phenotypic assays assessing susceptibility to antiviral drugs or for other assays. Following on from the first external quality assessment (EQA) for isolation and identification of influenza viruses using cell culture techniques in 2016, a follow up EQA was performed in 2019 for National Influenza Centres (NICs) in the World Health Organization (WHO) South East Asia and Western Pacific Regions. Nineteen WHO NICs performed influenza virus isolation and identification techniques on an EQA panel comprising 16 samples, containing influenza A or B viruses and negative control samples. One sample was used exclusively to assess capacity to measure a hemagglutination titer and the other 15 samples were used for virus isolation and subsequent identification. Virus isolation from EQA samples was generally detected by assessment of cytopathic effect and/or hemagglutination assay while virus identification was determined by real time RT-PCR, hemagglutination inhibition and/or immunofluorescence assays. For virus isolation from EQA samples, 6/19 participating laboratories obtained 15/15 correct results in the first EQA (2016) compared to 11/19 in the follow up (2019). For virus identification in isolates derived from EQA samples, 6/19 laboratories obtained 15/15 correct results in 2016 compared to 13/19 in 2019. Overall, NIC laboratories in the Asia Pacific Region showed a significant improvement between 2016 and 2019 in terms of the correct results reported for isolation from EQA samples and identification of virus in isolates derived from EQA samples (p=0.01 and p=0.02, respectively).

Для цитирования: Leung Vivian K Y, Deng Yi-Mo, Todd Angela, Peck Heidi, Buettner Iwona, Zakis Tasoula, Subbarao Kanta, Barr Ian G, Nahapetyan Karen, Inbanathan Francis Y, Samaan Magdi, Reading Patrick C. A second external quality assessment of isolation and identification of influenza viruses in cell culture in the Asia Pacific region highlights improved performance by participating laboratories.. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2021. DOI: 10.1016/j.jcv.2021.104907.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.